|From: kyleLennon (Rep: 0)||Date: 08/08/2018 23:03|
|Forum: Verastem, Inc. - Msg #103||Thread #674026954 (Rec: 0) |
|The shares of small oncology company rallied over 50% since mid-May, because the company's first product is likely to be approved by the FDA in October. The stock has garnered analyst interest as of lately. |
Verastem took advantages of the rise in share price to announce a secondary offering priced at $4.50 a share.
Let's look at the sentiment towards the VSTM stock. Our technical analysis shows that:
The stock short-term sentiment (next 30 days) is trending negative;
The mid-term sentiment (3-6 months) is trending positive;
The long-term sentiment (9-12 months) is positive.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.